Request for Covid-19 Impact Assessment of this Report
The United States Atovaquone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Atovaquone market, reaching US$ million by the year 2028. As for the Europe Atovaquone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Atovaquone players cover GSK, Lupin, Apotex, and Amneal Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Atovaquone market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
250mg
500mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Lupin
Apotex
Amneal Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Atovaquone Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Atovaquone by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Atovaquone by Country/Region, 2017, 2022 & 2028
2.2 Atovaquone Segment by Type
2.2.1 250mg
2.2.2 500mg
2.3 Atovaquone Sales by Type
2.3.1 Global Atovaquone Sales Market Share by Type (2017-2022)
2.3.2 Global Atovaquone Revenue and Market Share by Type (2017-2022)
2.3.3 Global Atovaquone Sale Price by Type (2017-2022)
2.4 Atovaquone Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.5 Atovaquone Sales by Application
2.5.1 Global Atovaquone Sale Market Share by Application (2017-2022)
2.5.2 Global Atovaquone Revenue and Market Share by Application (2017-2022)
2.5.3 Global Atovaquone Sale Price by Application (2017-2022)
3 Global Atovaquone by Company
3.1 Global Atovaquone Breakdown Data by Company
3.1.1 Global Atovaquone Annual Sales by Company (2020-2022)
3.1.2 Global Atovaquone Sales Market Share by Company (2020-2022)
3.2 Global Atovaquone Annual Revenue by Company (2020-2022)
3.2.1 Global Atovaquone Revenue by Company (2020-2022)
3.2.2 Global Atovaquone Revenue Market Share by Company (2020-2022)
3.3 Global Atovaquone Sale Price by Company
3.4 Key Manufacturers Atovaquone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atovaquone Product Location Distribution
3.4.2 Players Atovaquone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Atovaquone by Geographic Region
4.1 World Historic Atovaquone Market Size by Geographic Region (2017-2022)
4.1.1 Global Atovaquone Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Atovaquone Annual Revenue by Geographic Region
4.2 World Historic Atovaquone Market Size by Country/Region (2017-2022)
4.2.1 Global Atovaquone Annual Sales by Country/Region (2017-2022)
4.2.2 Global Atovaquone Annual Revenue by Country/Region
4.3 Americas Atovaquone Sales Growth
4.4 APAC Atovaquone Sales Growth
4.5 Europe Atovaquone Sales Growth
4.6 Middle East & Africa Atovaquone Sales Growth
5 Americas
5.1 Americas Atovaquone Sales by Country
5.1.1 Americas Atovaquone Sales by Country (2017-2022)
5.1.2 Americas Atovaquone Revenue by Country (2017-2022)
5.2 Americas Atovaquone Sales by Type
5.3 Americas Atovaquone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atovaquone Sales by Region
6.1.1 APAC Atovaquone Sales by Region (2017-2022)
6.1.2 APAC Atovaquone Revenue by Region (2017-2022)
6.2 APAC Atovaquone Sales by Type
6.3 APAC Atovaquone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Atovaquone by Country
7.1.1 Europe Atovaquone Sales by Country (2017-2022)
7.1.2 Europe Atovaquone Revenue by Country (2017-2022)
7.2 Europe Atovaquone Sales by Type
7.3 Europe Atovaquone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Atovaquone by Country
8.1.1 Middle East & Africa Atovaquone Sales by Country (2017-2022)
8.1.2 Middle East & Africa Atovaquone Revenue by Country (2017-2022)
8.2 Middle East & Africa Atovaquone Sales by Type
8.3 Middle East & Africa Atovaquone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atovaquone
10.3 Manufacturing Process Analysis of Atovaquone
10.4 Industry Chain Structure of Atovaquone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atovaquone Distributors
11.3 Atovaquone Customer
12 World Forecast Review for Atovaquone by Geographic Region
12.1 Global Atovaquone Market Size Forecast by Region
12.1.1 Global Atovaquone Forecast by Region (2023-2028)
12.1.2 Global Atovaquone Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Atovaquone Forecast by Type
12.7 Global Atovaquone Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Atovaquone Product Offered
13.1.3 GSK Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Lupin
13.2.1 Lupin Company Information
13.2.2 Lupin Atovaquone Product Offered
13.2.3 Lupin Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Lupin Main Business Overview
13.2.5 Lupin Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Atovaquone Product Offered
13.3.3 Apotex Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Amneal Pharmaceuticals
13.4.1 Amneal Pharmaceuticals Company Information
13.4.2 Amneal Pharmaceuticals Atovaquone Product Offered
13.4.3 Amneal Pharmaceuticals Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Amneal Pharmaceuticals Main Business Overview
13.4.5 Amneal Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Atovaquone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Atovaquone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 250mg
Table 4. Major Players of 500mg
Table 5. Global Atovaquone Sales by Type (2017-2022) & (K Units)
Table 6. Global Atovaquone Sales Market Share by Type (2017-2022)
Table 7. Global Atovaquone Revenue by Type (2017-2022) & ($ million)
Table 8. Global Atovaquone Revenue Market Share by Type (2017-2022)
Table 9. Global Atovaquone Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Atovaquone Sales by Application (2017-2022) & (K Units)
Table 11. Global Atovaquone Sales Market Share by Application (2017-2022)
Table 12. Global Atovaquone Revenue by Application (2017-2022)
Table 13. Global Atovaquone Revenue Market Share by Application (2017-2022)
Table 14. Global Atovaquone Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Atovaquone Sales by Company (2020-2022) & (K Units)
Table 16. Global Atovaquone Sales Market Share by Company (2020-2022)
Table 17. Global Atovaquone Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Atovaquone Revenue Market Share by Company (2020-2022)
Table 19. Global Atovaquone Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Atovaquone Producing Area Distribution and Sales Area
Table 21. Players Atovaquone Products Offered
Table 22. Atovaquone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Atovaquone Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Atovaquone Sales Market Share Geographic Region (2017-2022)
Table 27. Global Atovaquone Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Atovaquone Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Atovaquone Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Atovaquone Sales Market Share by Country/Region (2017-2022)
Table 31. Global Atovaquone Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Atovaquone Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Atovaquone Sales by Country (2017-2022) & (K Units)
Table 34. Americas Atovaquone Sales Market Share by Country (2017-2022)
Table 35. Americas Atovaquone Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Atovaquone Revenue Market Share by Country (2017-2022)
Table 37. Americas Atovaquone Sales by Type (2017-2022) & (K Units)
Table 38. Americas Atovaquone Sales Market Share by Type (2017-2022)
Table 39. Americas Atovaquone Sales by Application (2017-2022) & (K Units)
Table 40. Americas Atovaquone Sales Market Share by Application (2017-2022)
Table 41. APAC Atovaquone Sales by Region (2017-2022) & (K Units)
Table 42. APAC Atovaquone Sales Market Share by Region (2017-2022)
Table 43. APAC Atovaquone Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Atovaquone Revenue Market Share by Region (2017-2022)
Table 45. APAC Atovaquone Sales by Type (2017-2022) & (K Units)
Table 46. APAC Atovaquone Sales Market Share by Type (2017-2022)
Table 47. APAC Atovaquone Sales by Application (2017-2022) & (K Units)
Table 48. APAC Atovaquone Sales Market Share by Application (2017-2022)
Table 49. Europe Atovaquone Sales by Country (2017-2022) & (K Units)
Table 50. Europe Atovaquone Sales Market Share by Country (2017-2022)
Table 51. Europe Atovaquone Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Atovaquone Revenue Market Share by Country (2017-2022)
Table 53. Europe Atovaquone Sales by Type (2017-2022) & (K Units)
Table 54. Europe Atovaquone Sales Market Share by Type (2017-2022)
Table 55. Europe Atovaquone Sales by Application (2017-2022) & (K Units)
Table 56. Europe Atovaquone Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Atovaquone Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Atovaquone Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Atovaquone Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Atovaquone Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Atovaquone Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Atovaquone Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Atovaquone Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Atovaquone Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Atovaquone
Table 66. Key Market Challenges & Risks of Atovaquone
Table 67. Key Industry Trends of Atovaquone
Table 68. Atovaquone Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Atovaquone Distributors List
Table 71. Atovaquone Customer List
Table 72. Global Atovaquone Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Atovaquone Sales Market Forecast by Region
Table 74. Global Atovaquone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Atovaquone Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Atovaquone Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Atovaquone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Atovaquone Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Atovaquone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Atovaquone Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Atovaquone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Atovaquone Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Atovaquone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Atovaquone Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Atovaquone Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Atovaquone Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Atovaquone Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Atovaquone Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Atovaquone Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Atovaquone Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Atovaquone Revenue Market Share Forecast by Application (2023-2028)
Table 92. GSK Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Atovaquone Product Offered
Table 94. GSK Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Lupin Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 98. Lupin Atovaquone Product Offered
Table 99. Lupin Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Lupin Main Business
Table 101. Lupin Latest Developments
Table 102. Apotex Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 103. Apotex Atovaquone Product Offered
Table 104. Apotex Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
Table 107. Amneal Pharmaceuticals Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 108. Amneal Pharmaceuticals Atovaquone Product Offered
Table 109. Amneal Pharmaceuticals Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Amneal Pharmaceuticals Main Business
Table 111. Amneal Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Atovaquone
Figure 2. Atovaquone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atovaquone Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Atovaquone Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Atovaquone Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 250mg
Figure 10. Product Picture of 500mg
Figure 11. Global Atovaquone Sales Market Share by Type in 2021
Figure 12. Global Atovaquone Revenue Market Share by Type (2017-2022)
Figure 13. Atovaquone Consumed in Hospital
Figure 14. Global Atovaquone Market: Hospital (2017-2022) & (K Units)
Figure 15. Atovaquone Consumed in Drug Store
Figure 16. Global Atovaquone Market: Drug Store (2017-2022) & (K Units)
Figure 17. Global Atovaquone Sales Market Share by Application (2017-2022)
Figure 18. Global Atovaquone Revenue Market Share by Application in 2021
Figure 19. Atovaquone Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Atovaquone Revenue Market Share by Company in 2021
Figure 21. Global Atovaquone Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Atovaquone Revenue Market Share by Geographic Region in 2021
Figure 23. Global Atovaquone Sales Market Share by Region (2017-2022)
Figure 24. Global Atovaquone Revenue Market Share by Country/Region in 2021
Figure 25. Americas Atovaquone Sales 2017-2022 (K Units)
Figure 26. Americas Atovaquone Revenue 2017-2022 ($ Millions)
Figure 27. APAC Atovaquone Sales 2017-2022 (K Units)
Figure 28. APAC Atovaquone Revenue 2017-2022 ($ Millions)
Figure 29. Europe Atovaquone Sales 2017-2022 (K Units)
Figure 30. Europe Atovaquone Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Atovaquone Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Atovaquone Revenue 2017-2022 ($ Millions)
Figure 33. Americas Atovaquone Sales Market Share by Country in 2021
Figure 34. Americas Atovaquone Revenue Market Share by Country in 2021
Figure 35. United States Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Atovaquone Sales Market Share by Region in 2021
Figure 40. APAC Atovaquone Revenue Market Share by Regions in 2021
Figure 41. China Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Atovaquone Sales Market Share by Country in 2021
Figure 48. Europe Atovaquone Revenue Market Share by Country in 2021
Figure 49. Germany Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Atovaquone Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Atovaquone Revenue Market Share by Country in 2021
Figure 56. Egypt Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Atovaquone Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Atovaquone in 2021
Figure 62. Manufacturing Process Analysis of Atovaquone
Figure 63. Industry Chain Structure of Atovaquone
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...